Main Article Content
mixed solvency. Poloxamer 407 was used as thermosensitive polymer and carbopol 934P as mucoadhesive polymer. Initially solubility of domperidone was enhanced in aqueous solution by using various solubilizers like sodium citrate (SC), urea (UR), polyvinyl pyrrolidone (PVP), polyethylene glycol (PEG), propylene glycol (PG) etc, individually and as a combination of two, three, and four solvents, respectively. Maximum solubility of domperidone was achieved at 30% w/w solvent concentration, containing mixed blend of PVP K30 (7.5% w/w) + PEG 400 (7.5% w/w) + PEG 600 (7.5% w/w) + Propylene Glycol
(7.5% w/w), enhancing solubility of domperidone by 172.20 times as compared to its solubility in water. In situ gel was prepared by cold technique. Evaluation of the prepared gel was carried out, including properties like phase transition
temperature, viscosity, in vitro drug release, drug content, transnasal permeation and stability studies. In vitro drug release studies of aqueous solution of mixed blend were performed and permeability coefficient was found to be 1.576 Ã— 10-02
cm/hr and flux was found to be 8.64 Î¼g/cm2hr. Similarly in vitro studies for in situ nasal gel were performed and percent cumulative drug release was 73.05Â±0.57% in 6 h.Transnasal drug permeation studies results in flux value of 7.04 Î¼g/cm2hr and percent cumulative drug permeated across the membrane as 86.62Â±0.992%.The results from stability studies revealed that the prepared thermogel showed no significant decrease in drug content and no physicochemical change was observed upon storage in different temperature conditions resulting as a stable formulation.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
Illum L. Transport of drugs from the nasal cavity to the central nervous
system. Eur J Pharm Sci 2000;11:1-18.
Talegaonkar S, Mishra PR. Intranasal delivery: An approach to bypass
the blood brain barrier. Indian J Pharmacol 2004;36:140-147.
Sian LT, Lim F, Brown MB, Martin GP. Phisiological factors affecting nasal
drug delivery. In: Tauitou Elka, Barry Brian W, editors. Enhancement in
Drug Delivery. United Kingdom: CRC Press; 2006. p. 355-72.
Zia H, Dondeti P, Needham TE. Bioadhesive and formulation parameters
affecting nasal absorption. Int J Pharm 1995;127:115-33.
Bhise SB, Yadav AV, Avachat AM, Malayandi R. Bioavailability of
intranasal drug delivery system. Asian J Pharm 2008;2:201-15.
Maheshwari RK, Rajagopalan R. Solubilization of ibuprofen by mixed
solvency approach. Indian Pharm 2009;8:81-4.
Maheshwari RK. "Mixed solvency approach" boon for solubilization of
poorly water soluble drugs. Asian J Pharm 2010;1:60-3.
Maheshwari RK. Mixed solvency- A novel concept for solubilization of
poorly water souble drugs. J Tech Eng Sci 2009;1:39-43.
Shah S, Agrawal M, Agrawal A. Solubilization of furosemide by mixed
solvency approch. J Pharm Res 2010;3:2732-3.
Zaki NM, Awad GA, Mortada ND, Abd Elhady SS. Enhanced bioavalibility of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 2007;32:296-307.
Pisal SS, Padarkar AR, Mahadik KR, Kadam SS. Pluronic gels for nasal
delivery of Vitamin B12. Part I: preformulation study. Int J Pharm
Pisal SS, Reddy P, Padarkar AR, Mahadik KR, Kadam SS. Nasal melatonin gels using pluronic PF-127 for chronobiological treatment of sleep disorder. Indian J Biotech 2004;3:369-77.
Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RS. Thermoreversible-
mucoadhesive gel for nasal delivery of sumatriptan. AAPS Pharmscitech
Maheshwari RK, Indurkhya A. Formulation and evaluation of aceclofenac injection made by mixed hydrotropic solubilization technique. Iran J Pharm Sci 2010;9:233-42.
Mahajan HS, Gattani SG. Gellan gum based microparticles of
metoclopromide hydrochloride for intranasal delivery: development
and evaluation. Chem Pharm Bull (Tokyo) 2009;57:388-392.
Pisal S, Shelke V, Mahadik K, Kadam S. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. AAPS
Maheshwari RK. Solid dispersion and syrup formulation of poorly water
soluble drugs by hydrotropy. Indian Pharm 2006;70:22-30.